Stealth BioTherapeutics (Stealth BioTherapeutics) Total Liabilities : $89.23 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Total Liabilities?

Stealth BioTherapeutics's Total Liabilities for the quarter that ended in Mar. 2022 was $89.23 Mil.

Stealth BioTherapeutics's quarterly Total Liabilities increased from Sep. 2021 ($73.02 Mil) to Dec. 2021 ($95.52 Mil) but then declined from Dec. 2021 ($95.52 Mil) to Mar. 2022 ($89.23 Mil).

Stealth BioTherapeutics's annual Total Liabilities increased from Dec. 2019 ($35.48 Mil) to Dec. 2020 ($46.22 Mil) and increased from Dec. 2020 ($46.22 Mil) to Dec. 2021 ($95.52 Mil).

Stealth BioTherapeutics Total Liabilities Historical Data

The historical data trend for Stealth BioTherapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Total Liabilities Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Liabilities

Get a 7-Day Free Trial

298.44

402.23

35.48

46.22

95.52

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Liabilities	Get a 7-Day Free Trial															46.86	58.57	73.02	95.52	89.23

Stealth BioTherapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Stealth BioTherapeutics's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.828	+	(13.656	+	71.037
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	95.52

Total Liabilities	=	Total Assets (A: Dec. 2021 )	-	Total Equity (A: Dec. 2021 )
	=	50.226	-	-45.295
	=	95.52

Stealth BioTherapeutics's Total Liabilities for the quarter that ended in Mar. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.889	+	(13.782	+	65.561
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	89.23

Total Liabilities	=	Total Assets (Q: Mar. 2022 )	-	Total Equity (Q: Mar. 2022 )
	=	36.915	-	-52.317
	=	89.23

Stealth BioTherapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.